Call for collaboration by Johnson & Johnson Innovation France

In March 2021, the Institut Pasteur and the Paris Public Hospital Network (AP-HP) signed a three-year collaboration agreement with Janssen Biotech, the R&D partner of Janssen France, one of the pharmaceutical companies in the Johnson & Johnson, Inc. group.

The agreement has already led to several successful collaborative projects between the Institut Pasteur and Johnson & Johnson, one of the key accounts managed by the Technology Transfer and Industrial Partnership Department (DARRI).

Confirming its interest in working closely with French academic scientists, including those at the Institut Pasteur, Johnson & Johnson is launching a call for collaboration in the following pharmaceutical areas of interest: infectious diseases and vaccines, oncology, neuroscience, immunology, and data science (see below for details about these areas of interest).

Up to €1 million in funds may be allocated.

To help identify innovative proposals for collaboration, the DARRI would like to organize a discussion seminar in March or April between the scientists at Johnson & Johnson and any PIs at the Institut Pasteur who are interested in this opportunity.

 

Download the presentation with the areas of interest targeted by the call

 

For more information about the call or to register for the seminar, please contact:

 

Vincent Charpentier (Technology Transfer Department/DARRI)

Serge Pauillac (Innovation and Entrepreneurship Detection and Funding Department/DARRI)